Valacyclovir Hydrochloride Tablet, Film Coated
Product Images NDC 59746-325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valacyclovir Hydrochloride (NDC 59746-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label2 (1gramlabel)

Label2 (1gramlabel)
Valacyclovir Tablets are a medication prescribed for the treatment of herpes virus infections, such as genital herpes, shingles, and cold sores. Each tablet contains 1 gram of Valacyclovir Hydrochloride USP, which is equivalent to Valacyclovir. The usual dosage should be taken as per the prescribing information provided with the medication. The tablets should be kept out of reach of children and should be disbursed in a tightly closed container as recommended by USP. They should be stored at a temperature between 15°C and 30°C. These tablets are manufactured by Jubilant Generics Ltd in India and marketed by Jubilant Cadista Pharmaceuticals Inc. in the USA. The product is available in a pack of 30 tablets and should be dispensed with an accompanying patient information leaflet for each patient. However, the text also contains errors and incomplete sentences.*
FDA Label Image

Label1 (500mglabel)

Label1 (500mglabel)
This is a medicine called Valacyclovir Hydrochloride. It is a film-coated tablet with each containing 500 mg of Valacyclovir. The usual dosage is not available, so the accompanying prescribing information should be referred to. The tablets should be kept out of reach of children, dispensed in a well-closed container, and stored at 20°C to 25°C. They are manufactured by Jubiant Generics Ltd. in Roorkee, India and marketed by Jubiant Cadista Pharmaceuticals Inc. in Salisbury, MD, USA. The tablets are available in a pack of 30 and the accompanying patient information leaflet should be provided to each patient.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.